;

Bill C-9

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

PDF

SCHEDULE 1
(Definition "pharmaceutical product" in section 21.02 and paragraph 21.03(1)(a))